Literature DB >> 9001864

Acne. An overview of clinical research findings.

D M Thiboutot1.   

Abstract

Although acne represents the most common chronic skin condition seen by dermatologists, there are still many unanswered questions regarding its pathophysiology, and patients are still in need of more effective therapies, particularly those aimed at the hormonal aspects of acne. Recent clinical research has led to advances in our understanding of factors such as cytokines in follicular hyperkeratinization and the role of androgens in acne, the emergence and significance of antibiotic resistance of P. acnes, the long-term safety and efficacy of isotretinoin, and the safety and efficacy of new topical retinoids, such as tazarotene and adapalene. Fruitful interactions between basic scientists and clinical researchers within medicine and the pharmaceutical industry will, it is hoped, provide for future advances in this area.

Entities:  

Mesh:

Year:  1997        PMID: 9001864     DOI: 10.1016/s0733-8635(05)70418-6

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  5 in total

1.  Genome sequence and analysis of a Propionibacterium acnes bacteriophage.

Authors:  Mark D Farrar; Karen M Howson; Richard A Bojar; David West; James C Towler; James Parry; Katharine Pelton; Keith T Holland
Journal:  J Bacteriol       Date:  2007-03-30       Impact factor: 3.490

Review 2.  Acne vulgaris.

Authors:  Ertuğrul H Aydemir
Journal:  Turk Pediatri Ars       Date:  2014-03-01

3.  Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect.

Authors:  Bong Seon Kang; Jae-Gu Seo; Gwa-Su Lee; Jung-Hwa Kim; Sei Yeon Kim; Ye Won Han; Hoon Kang; Hyung Ok Kim; Ji Hwan Rhee; Myung-Jun Chung; Young Min Park
Journal:  J Microbiol       Date:  2009-02-20       Impact factor: 3.422

4.  The protective effects of melittin on Propionibacterium acnes-induced inflammatory responses in vitro and in vivo.

Authors:  Woo-Ram Lee; Kyung-Hyun Kim; Hyun-Jin An; Jung-Yeon Kim; Young-Chae Chang; Hyun Chung; Yoon-Yub Park; Myeong-Lyeol Lee; Kwan-Kyu Park
Journal:  J Invest Dermatol       Date:  2014-02-04       Impact factor: 8.551

5.  Efficacy and safety of an oral contraceptive containing ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) in three indications in the People's Republic of China: a comparison with international studies.

Authors:  Joachim Marr; Zirong Huang; Baoxi Wang; Hongyan Zhang; Katrin Roth
Journal:  Open Access J Contracept       Date:  2015-07-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.